期刊文献+

RKIP的表达与肺癌侵袭转移的相关性 被引量:1

Correlation of RKIP expression and invasion and metastasis of lung cancer
原文传递
导出
摘要 目的探讨Raf激酶抑制蛋白(RKIP)在肺癌组织中的表达及其与肺癌侵袭转移的相关性。方法采用RT-PCR和Western blot方法检测95例肺癌患者的肺癌组织及其癌旁正常肺组织中RKIP的表达,分析其与肺癌临床病理学特征的关系。结果肺癌组织RKIP mRNA阳性表达率和蛋白表达量均低于正常肺组织(48.42%vs.77.89%和0.598±0.124vs.0.623±0.116),肺癌中、低分化组均低于高分化组[(39.47%、20.00%vs.66.67%)和0.318±0.117、0.104±0.005vs.0.623±0.116),伴有淋巴结转移组低于无淋巴结转移组(31.71%vs.61.11%和0.309±0.112vs.0.737±0.175),生存期<2年者低于生存期≥2年者(34.78%vs.61.22%和0.302±0.107vs.0.742±0.225)(P<0.05)。结论 RKIP的低表达可能与肺癌的发生及侵袭转移有关。 Objective To investigate the expression of Raf kinase inhibitor protein(RKIP) in lung cancer and its correlation with the invasion and metastasis of lung carcer. Methods The expressions of RKIP in lung cancer(group A) and tumor-adjacent normal lung tissues(group B) were detected by RT-PCR and Western blot in 95 patients with lung cancer. The relationship of RKIP expression with elinicopathologic features was analyzed. Results The RKIP mRNA positive expression rate and protein expression were lower in group A than those in group B[(48. 42% vs. 77. 89%) and (0. 598±0. 124 vs. 0. 623±0. l16)],which in group A were lower in moderately and poorly differentiated groups than those in well differentiated group[(39.47M, 20.00% vs. 66.67%) and (0. 318±0. 117,0. 104±0. 005 vs. 0. 623±0. ll6)],lower in the cases with lymphatic metastasis than those without[(31.71% vs. 61.11%) and (0. 309_+0. 112 vs. 0. 737±0. 175)],and lower in the cases with survival time 〈2 years than those ≥2 years [(34. 78%vs. 61.22%) and (0. 302±0. 107 vs. 0. 742 ± 0. 225)] (P〈0. 05). Conclusion The low expression of RKIP may be correlated with carcinogenesis, invasion and metastasis of lung cancer.
出处 《江苏医药》 CAS 北大核心 2013年第13期1525-1527,共3页 Jiangsu Medical Journal
基金 河北省科技计划项目(12277723)
关键词 RAF激酶抑制蛋白 肺癌 Raf kinase inhibitor protein Lung cancer
  • 相关文献

参考文献10

  • 1Tang H, Park S, Sun SC, et al. RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex[J ]. FEBS Lett, 2010, 584 (4): 662-668.
  • 2Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target[J]. Expert Opin Ther Targets, 2008, 12 (10):1275- 1287.
  • 3Beshir AB, Ren G, Magpusao AN, et al. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression[J]. Cancer Lett, 2010,299 (2) : 137-149.
  • 4Xinzhou H, Ning Y,Ou W, et al. RKIP inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix[J]. Mol Biol(Mosk), 2011, 45(6):1004-1011.
  • 5Shi SY,Rath O, Zebisch A, et al. Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epitheliabmesenchymal transition[J]. Cancer Res, 2010,70(17) : 6715-6724.
  • 6Xu YF, Yi Y, Oiu SJ, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infeetion[J]. J Hepatol,2010,53(5) :872-879.
  • 7Lin K,Baritaki S,Militello L,et al. The Role of B RAF Mutations in Melanoma and the Induction of EMT via Dysregula- tion of the NF-κB/SnaiI/RKIP/PTEN Circuit [J]. Genes Cancer, 2010,1(5) :409-420.
  • 8Li HZ, Gao Y, Zhao XL, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer[J]. Mol Cancer Res, 2009,7 (6) : 832-840.
  • 9Karamitopoulou E, Zlobec I,Panayiotides I, et al. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer[J]. Hum Pathol, 2011,42(12): 1888-1896.
  • 10Lee HC, Tian B, Sedivy J M, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells[J]. Gastroenterology, 2006, 131 (4): 1208- 1217.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部